Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity.

Huber VC, Arulanandam BP, Arnaboldi PM, Elmore MK, Sheehan CE, Kallakury BV, Metzger DW. Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. Int Immunopharmacol. 2003 Jun; 3(6):801-9.

View in: PubMed

authors with profiles

Bernard Arulanandam

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support